Ozempic-maker Novo Nordisk briefly becomes Europe's most valuable firm
Novo Nordisk briefly overtakes LVMH as Europe's most valuable company
Ozempic maker overtakes LVMH as biggest European company - Pharma News
Ozempic-maker Novo Nordisk briefly becomes Europe's most valuable firm
Novo Nordisk Becomes Europe's Most Valuable Company
Weight-loss drug frenzy lifts Novo Nordisk as Europe's most valuable company
Bernard Arnault's LVMH sees slow quarterly sales growth
The Luxury Empire: LVMH's Most Notable Acquisitions Since Inception - Quartr Insights
Ozempic and Wegovy, Novo Nordisk's Weight Loss Drugs, Reshape Denmark's Economy - The New York Times
Novo Nordisk surpasses LVMH to become Europe's largest listed company - Luxus Plus
Novo Nordisk briefly eclipses LVMH as Europe's most valuable company